Hypoxic/ischemic neonatal brain injury is a major cause of learning disabilities, cerebral palsy, epilepsy and death. The development of neuroprotective strategies to combat this problem requires a greater understanding of the mechanism of neuroprotection. The goal of this research proposal is to determine the molecular mechanism(s) underlying the neuroprotective action of acidic fibroblast growth factor (FGF-1) and scatter factor/hepatocyte growth factor (SF/HGF) against hypoxic/ischemic injury in neonatal brain.
In Aim 1, we will use complementary in vitro and in vivo models to determine the relative roles of NMDA and AMPA receptor-mediated excitotoxicity in hypoxic/ischemic injury, and its protection by FGF-1 and SF/HGF. Results will establish the relationship between the extent of brain injury and NMDA and AMPA receptor-mediated excitotoxicity triggered by hypoxia/ischemia, selective neuronal vulnerability to hypoxia/ischemia, and excitatory amino acid receptor-specific mechanism of FGF-1 and SF/HGF protection in neonatal brain. Effects of FGF-1 and SF/HGF on NMDA and AMPA receptor expression and regulatory phosphorylation events will also be determined.
Aim 2 will investigate the discrete second messenger pathways and transcription factors that are required for FGF- 1- and SF/HGF-mediated neuroprotection against hypoxic/ischemic injury. We will use complementary in vitro and neonatal rat hypoxia/ischemia models to examine if specific second messengers and transcriptional regulators primarily downstream of principal investigator3-kinase/Akt signaling pathway mediate FGF- 1 and SF/HGF protection. We will focus on the roles of glycogen synthase kinase-3 alpha/beta (GSK-3alpha/beta), hypoxia inducible factor-1 (HIF-1) and nuclear factor-KappaB (NF-KappaB).
In Aim 3 we will determine the role of regulators of the apoptotic cascade in hypoxic/ischemic neonatal brain injury and their involvement in the neuroprotective actions of FGF-1 and SF/HGF. Complementary in vitro and in vivo models will be used to focus on the caspase cascade and its target PARP. Regulators of the caspase cascade such as inhibitors of apoptosis proteins (IAPs) and secondary mitochondria-derived caspase activator (SMAC) will be examined. Results of these experiments in conjunction with those of Aim 2 will allow us to elucidate the antiapoptotic molecular mediators and their regulation by specific second messengers and transcription factors involved in neuroprotection by FGF-1 and SF/HGF against neonatal hypoxic/ischemic brain injury. Experiments outlined in this proposal will identify the specific molecular mechanism by which neuroprotective growth factors protect against hypoxic/ischemic injury in neonatal brain. Our findings will contribute to the development of therapeutic strategies for treating hypoxic ischemic neonatal brain injury.

National Institute of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1-BDCN-3 (01))
Program Officer
Golanov, Eugene V
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Hugo W. Moser Research Institute Kennedy Krieger
United States
Zip Code
Thatipamula, Shabarish; Al Rahim, Md; Zhang, Jiangyang et al. (2015) Genetic deletion of neuronal pentraxin 1 expression prevents brain injury in a neonatal mouse model of cerebral hypoxia-ischemia. Neurobiol Dis 75:15-30
Thatipamula, Shabarish; Hossain, Mir Ahamed (2014) Critical role of extracellularly secreted neuronal pentraxin 1 in ischemic neuronal death. BMC Neurosci 15:133
Sharma, Jaswinder; Johnston, Michael V; Hossain, Mir Ahamed (2014) Sex differences in mitochondrial biogenesis determine neuronal death and survival in response to oxygen glucose deprivation and reoxygenation. BMC Neurosci 15:9
Al Rahim, Md; Thatipamula, Shabarish; Hossain, Mir Ahamed (2013) Critical role of neuronal pentraxin 1 in mitochondria-mediated hypoxic-ischemic neuronal injury. Neurobiol Dis 50:59-68
Al Rahim, Md; Hossain, Mir Ahamed (2013) Genetic deletion of NP1 prevents hypoxic-ischemic neuronal death via reducing AMPA receptor synaptic localization in hippocampal neurons. J Am Heart Assoc 2:e006098
Russell, Juliet C; Kishimoto, Koji; O'Driscoll, Cliona et al. (2011) Neuronal pentraxin 1 induction in hypoxic-ischemic neuronal death is regulated via a glycogen synthase kinase-3?/? dependent mechanism. Cell Signal 23:673-82
Sharma, Jaswinder; Nelluru, Geetha; Wilson, Mary Ann et al. (2011) Sex-specific activation of cell death signalling pathways in cerebellar granule neurons exposed to oxygen glucose deprivation followed by reoxygenation. ASN Neuro 3:
Hossain, Mir Ahamed (2008) Hypoxic-ischemic injury in neonatal brain: involvement of a novel neuronal molecule in neuronal cell death and potential target for neuroprotection. Int J Dev Neurosci 26:93-101
Russell, Juliet C; Whiting, Heather; Szuflita, Nicholas et al. (2008) Nuclear translocation of X-linked inhibitor of apoptosis (XIAP) determines cell fate after hypoxia ischemia in neonatal brain. J Neurochem 106:1357-70
Russell, J C; Blue, M E; Johnston, M V et al. (2007) Enhanced cell death in MeCP2 null cerebellar granule neurons exposed to excitotoxicity and hypoxia. Neuroscience 150:563-74

Showing the most recent 10 out of 12 publications